IBAB — Ion Beam Applications SA Share News
0.000.00%
- €491.66m
- €566.81m
- €620.18m
Brief: Iba Signs Contract For Be Efficient Sterilization Solution In Germany
Brief: IBA Says First Patient Treated In C-Flash-01 Conformalflash Clinical Trial
Brief: IBA Selected To Support The US Expansion Of Radiopharmaceutical Producer
Brief: IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QIS
Brief: IBA Signs Contract To Install First Proton Therapy Center In Rome, Italy
Brief: IBA, Penn Medicine Announce Noventra Oncology Alliance Joint Venture
Lead PFAROS Initiative
IBA rises on improved proton therapy profitability
Particle accelerator firm IBA's H1 revenue up 6% on equipment order intake growth
Brief: IBA H1 Total Net Sales €323.7 Mln, Outlook 2026 Confirmed
Brief: Ion Beam Applications H1 Pretax Profit EUR 12.3 Million
Brief: IBA To Install First Proton Therapy Center In Brazil
Belgium's IBA rises on governance shift, analysts flag PanTera stake potential
Brief: IBA Appoints Olivier Legrain As Vice-Chairman Of Board
Brief: IBA: Research Agreement With MD Anderson Cancer Center
Brief: IBA Signs Contract With Duke University Health System
Brief: IBA Reports Stable Backlog At EUR 1.6 Bln, Reiterates 2026 Adjusted EBIT Guidance
Belgium's IBA FY 2025 sales beat expectations on proton therapy growth
Brief: IBA Eyes 2026 Group Adjusted EBIT Of At Least EUR 32 Million